Literature DB >> 21658782

Higher n-3 fatty acids are associated with more intense fenfluramine-induced ACTH and cortisol responses among cocaine-abusing men.

Laure Buydens-Branchey1, Marc Branchey, Joseph R Hibbeln.   

Abstract

Preclinical studies have shown that diets supplemented with or deficient in n-3 polyunsaturated fatty acids (PUFAs) could influence serotonergic neurotransmission, but information about their effects on the serotonergic function of humans is scant. Therefore, simultaneous assessments of n-3 PUFAs and of the adrenocorticotropic hormone (ACTH) and cortisol responses to challenges with the serotonin (5-HT) probe d,l-fenfluramine (FEN) were performed in 25 cocaine-abusing men and 12 control subjects. Cocaine abusers were tested 18 days after their admission to a closed ward. ACTH and cortisol were measured in plasma samples collected on two testing days separated by 48 h following the random administration of 60 mg of FEN or placebo. Fatty acids were measured in the first test day samples. Patients' FEN-induced ACTH rises were significantly and positively correlated with docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). Patients' cortisol rises were positively and significantly correlated with EPA but not with DHA. There were no significant correlations between hormonal responses and pre-hospitalization cocaine use parameters. Control subjects' responses to FEN were not correlated with any PUFA. In conclusion, higher EPA and DHA levels were associated with a more intense FEN-induced ACTH response and higher EPA levels with a more intense cortisol response in cocaine-abusing men withdrawn from cocaine but not in control subjects. These findings support and expand existing evidence that EPA and DHA could influence 5-HT function in some human subgroups. 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658782      PMCID: PMC3146589          DOI: 10.1016/j.psychres.2011.05.027

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  34 in total

1.  Serotonergic responsiveness in human cocaine users.

Authors:  Udi E Ghitza; Richard B Rothman; David A Gorelick; Jack E Henningfield; Michael H Baumann
Journal:  Drug Alcohol Depend       Date:  2006-08-23       Impact factor: 4.492

Review 2.  Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.

Authors:  Marlene P Freeman; Joseph R Hibbeln; Katherine L Wisner; John M Davis; David Mischoulon; Malcolm Peet; Paul E Keck; Lauren B Marangell; Alexandra J Richardson; James Lake; Andrew L Stoll
Journal:  J Clin Psychiatry       Date:  2006-12       Impact factor: 4.384

Review 3.  Bioactive lipids in schizophrenia.

Authors:  Gregor E Berger; Stefan Smesny; G Paul Amminger
Journal:  Int Rev Psychiatry       Date:  2006-04

Review 4.  Omega-3 fatty acids and mood disorders.

Authors:  Gordon Parker; Neville A Gibson; Heather Brotchie; Gabriella Heruc; Anne-Marie Rees; Dusan Hadzi-Pavlovic
Journal:  Am J Psychiatry       Date:  2006-06       Impact factor: 18.112

5.  n-3 polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice.

Authors:  S Vancassel; S Leman; L Hanonick; S Denis; J Roger; M Nollet; S Bodard; I Kousignian; C Belzung; S Chalon
Journal:  J Lipid Res       Date:  2007-11-08       Impact factor: 5.922

6.  Long-term dietary lipid regimen alters adrenocortical function at the cellular level.

Authors:  R V Carsia; H Weber; P J McIlroy; C E Hock
Journal:  Horm Metab Res       Date:  2008-09-22       Impact factor: 2.936

Review 7.  The role of eicosanoids in the brain.

Authors:  Daniella Tassoni; Gunveen Kaur; Richard S Weisinger; Andrew J Sinclair
Journal:  Asia Pac J Clin Nutr       Date:  2008       Impact factor: 1.662

Review 8.  Omega 3 fatty acids and the brain: review of studies in depression.

Authors:  Andrew J Sinclair; Denovan Begg; Michael Mathai; Richard S Weisinger
Journal:  Asia Pac J Clin Nutr       Date:  2007       Impact factor: 1.662

9.  Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils.

Authors:  M Cansev; R J Wurtman
Journal:  Neuroscience       Date:  2007-08-01       Impact factor: 3.590

10.  A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.

Authors:  Pao-Yen Lin; Kuan-Pin Su
Journal:  J Clin Psychiatry       Date:  2007-07       Impact factor: 4.384

View more
  5 in total

Review 1.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

2.  Eicosapentaenoic acid suppression of systemic inflammatory responses and inverse up-regulation of 15-deoxyΔ(12,14) prostaglandin J2 production.

Authors:  Jillian Davidson; Warren Higgs; Dino Rotondo
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

3.  Targeted alterations in dietary n-3 and n-6 fatty acids improve life functioning and reduce psychological distress among patients with chronic headache: a secondary analysis of a randomized trial.

Authors:  Christopher E Ramsden; Keturah R Faurot; Daisy Zamora; Olafur S Palsson; Beth A MacIntosh; Susan Gaylord; Ameer Y Taha; Stanley I Rapoport; Joseph R Hibbeln; John M Davis; J Douglas Mann
Journal:  Pain       Date:  2015-04       Impact factor: 7.926

4.  Comprehensive profiling of plasma fatty acid concentrations in young healthy Canadian adults.

Authors:  Salma A Abdelmagid; Shannon E Clarke; Daiva E Nielsen; Alaa Badawi; Ahmed El-Sohemy; David M Mutch; David W L Ma
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

Review 5.  Linking What We Eat to Our Mood: A Review of Diet, Dietary Antioxidants, and Depression.

Authors:  Qingyi Huang; Huan Liu; Katsuhiko Suzuki; Sihui Ma; Chunhong Liu
Journal:  Antioxidants (Basel)       Date:  2019-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.